Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors

• Author(s): Chícharo, Ana Teodósio ; Lopes, Ana R. ; Barreira, Sofia ; Pinto, Luísa ; Machado, Ana R. Cruz ; Capela, Susana
• Date: 2024
• Persistent ID: http://hdl.handle.net/10400.1/26402
• Origin: Sapientia - Universidade do Algarve
• Subject(s): Pregnancy; Rheumatic disorders; Mothers; Perinatal period; Tumor necrosis factor inhibitors; Biosimilar pharmaceuticals
• Document Type: Journal article
• Language: English
• Contributor(s): Sapientia

Description

No safety or efficacy issues arose from using biosimilar TNFi during conception or pregnancy.